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G Protein-Coupled Inwardly Rectifying K1 Channels
(GIRKs) Mediate Postsynaptic but Not Presynaptic
Transmitter Actions in Hippocampal Neurons
Christian LuÈ scher,1 Lily Y. Jan,2,3,5 (Karschin et al., 1996; Liao et al., 1996; Ponce et al.,
1996; Drake et al., 1997). It is thought that native chan-Markus Stoffel,6 Robert C. Malenka,3,4
and Roger A. Nicoll1,3,7 nels consist of tetramers and that they are likely to con-
tain at least two different subunits (Duprat et al., 1995;1Department of Cellular and Molecular Pharmacology
2Department of Biochemistry Kofuji et al., 1995; Krapivinsky et al., 1995; Lesage et
al., 1995; Hedin et al., 1996; Spauschus et al., 1996).3Department of Physiology
4Department of Psychiatry Despite a large amount of research on the mecha-
nisms underlying neurotransmitter action, the role of5Howard Hughes Medical Institute
University of California GIRKs in pre- and postsynaptic inhibition in the CNS is
unclear. For instance, it is not clear what role, if any,San Francisco, California
94143 GIRKs play in the presynaptic inhibition induced by G
protein-coupled receptors. Alternate hypotheses in-6The Laboratory of Metabolic Diseases and
Molecular Cell Biology volve the inhibition of Ca21 channels (Dittman and Re-
gehr, 1996; Takahashi et al., 1996; Wuand Saggau, 1997)Rockefeller University
New York, New York 10021 or a direct interaction with the release machinery down-
stream of Ca21 entry (Scanziani et al., 1992; Thompson
et al., 1993).
On the postsynaptic side, there is evidence that K1Summary
channels with different properties can be activated by
different G protein-coupled receptors in the hippocam-To study the role of G protein-coupled, inwardly recti-
pus (Ogata et al., 1987; MuÈ ller and Misgeld, 1989; Prem-fying K1 (GIRK) channels in mediating neurotransmit-
kumar and Gage, 1994; Jarolimek et al., 1994).ter actions in hippocampal neurons, we have exam-
Decisive studies are still missing, mainly due to theined slices from transgenic mice lacking the GIRK2
lack of specific pharmacological antagonists for GIRKs.gene. The outward currents evoked by agonists for
We have taken advantage of the recent development ofGABAB receptors, 5HT1A receptors, and adenosine A1
mutant mice that lack the GIRK2 protein (Signorini etreceptors were essentially absent in mutant mice,
al., 1997), which also show a marked posttranscriptionalwhile the inward current evoked by muscarinic recep-
and probably posttranslational down-regulation of thetor activation was unaltered. In contrast, the pre-
GIRK1 protein. These mice exhibit spontaneous seizuresynaptic inhibitory action of a number of presynaptic
activity, suggesting impaired inhibition, but otherwisereceptors on excitatory and inhibitory terminals was
appear normal.unaltered in mutant mice. These included GABAB,
adenosine, muscarinic, metabotropic glutamate, and
NPY receptors on excitatory synapses and GABAB and Results
opioid receptors on inhibitory synapses. These find-
ings suggest that a number of G protein-coupled re- Elimination of Hyperpolarizing Responses to
ceptors activate the same class of postsynaptic K1 Activation of GABAB, 5HT1A, and Adenosine
channel, which contains GIRK2. In addition, the GIRK2 A1 Receptors in GIRK22/2 Hippocampal
channels play no role in the inhibition mediated by Principal Cells
presynaptic G protein-coupled receptors, suggesting In the first series of experiments, we examined the ac-
that the same receptor can couple to different effector tions of a number of G protein-coupled receptors on
systems according to its subcellular location in the the holding current recorded in CA1 and CA3 pyramidal
neuron. cells and dentate gyrus granule cells. A typical experi-
ment is shown in Figure 1A for the selective GABAB
Introduction agonist baclofen, which is known to activate K1 chan-
nels via a G protein (Andrade et al., 1986; Thompson
Neurotransmitters activate one or both of two classes and GaÈ hwiler, 1992). In the GIRK22/2 mouse, baclofen
of receptor: ligand-gated ion channels and G protein- had no effect on the holding current or on the input
coupled receptors. A large number of G protein-coupled resistance (Rin; Figure 1A1) in a CA1 pyramidal cell. Ap-
receptors have been shown to hyperpolarize cells by plication of the same concentration of baclofen (40 mM)
activating inwardly rectifying K1 channels (GIRKs) in for the same period of time to a CA1 pyramidal cell from
postsynaptic neurons of the CNS as well as to inhibit a wild-type animal (1/1) elicited an outward current and
the release of neurotransmitter presynaptically by an a decrease in the input resistance (Figure 1A2). This
unknown mechanism (Nicoll, 1988; North, 1989; Thomp- experiment was repeated a number of times for baclo-
son et al., 1993; Wu and Saggau, 1997). Four different fen, not only in CA1 pyramidal cells but also in CA3
mammalian GIRK channel subunits have been cloned. pyramidal cells and dentate granule cells (Figure 1B).
GIRK1±3 are expressed in high levels by CA1 and CA3 The outward current was greatly (.85%) reduced in the
pyramidal cells as well as by dentate granule cells CA1 pyramidal cells, although a small outward current
remained. The size of the outward current induced by
the same concentration of baclofen was progressively7 To whom correspondence should be addressed.
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Figure 1. Reduction of G Protein-Coupled
Receptor-Mediated Outward Currents in the
GIRK22/2 Mouse
(A1) Holding current (upper trace) and input
resistance (lower trace) of a representative
CA1 pyramidal cell in voltage clamp (Vh 5 279
mV) in a GIRK22/2 mouse. Neither parameter
changed when baclofen (40 mM) was applied
to the bath.
(A2) In a GIRK21/1 cell, bath application of
baclofen led to an outward current (upper
trace, Vh 5 279 mV), which was associated
with a decrease of the input resistance (lower
trace), suggesting the opening of a K1 con-
ductance. The holding current at rest is
smaller for the wild-type compared to the
GIRK22/2 mouse, suggesting a difference in
resting membrane potential.
(B) Summary graph of all agonists tested
(mean 6 SEM). The amplitude of the outward
current (DIh) caused by the application of
baclofen and adenosine was significantly re-
duced in CA1 and CA3 neurons (**, p , 0.001;
*, p , 0.01). In CA1, baclofen induced a resid-
ual outward current of 10.9 6 4.1 pA (p ,
0.05 for a hypothesized mean of zero; see
text for discussion). 5-HT elicited an outward
current in the GIRK21/1 mouse and an inward
current in the GIRK22/2 mouse, most proba-
bly due to uncovering the effects of a 5-HT4
receptor. The amplitude of a carbachol-
induced inward current was not different in
mutant and control mice. Concentrations ap-
plied in CA1 were (in mM) 40 baclofen (Baclo;
n 5 7, 2/2; n 5 5, 1/1), 100 adenosine (Ad-
eno; n 5 5, 2/2; n 5 4, 1/1), 60 serotonin
(5-HT; n 5 3, 2/2; n 5 3, 1/1), and 10 carba-
chol (Carb; n 5 3, 2/2; n 5 3, 1/1). In CA3
and dentate gyrus, n 5 3 for each drug and
genotype.
smaller in CA3 pyramidal cells and granule cells of wild- Storm, 1990). At lower concentrations (1±10 mM), carba-
chol selectively closes the leak channels (Madison ettype mice butwas completelyabsent in the mutant mice.
We next examined theaction of a number of additional al., 1987). This latter action of carbachol was unaltered
in the mutant mice (Figure 1B), suggesting that the mus-neurotransmitter receptor agonists that are known to
modulate postsynaptic K1 channel activity. The post- carinic receptor-sensitive leak channels are not GIRKs.
To characterize the baclofen-activated current insynaptic action of adenosine, which activates K1 chan-
nels via an A1 receptor (Trussell and Jackson, 1987; more detail, voltage ramps were carried out in the ab-
sence and presence of baclofen (Figure 2A). The baclo-Nicoll, 1988; Thompson et al., 1992), was abolished in
the mutant mice in all three types of hippocampal neu- fen-induced current was then obtained by calculating
the difference between the two curves (Figure 2B). Therons (Figure 1B). Serotonin (5-HT), which also activates
K1 channels via 5-HT1A receptors (Andrade and Nicoll, slope conductance of the current in the mutant mouse
is much smaller than in the wild-type mouse, but it still1987; Colino and Halliwell, 1987), actually induced an
inward current and an increase of input resistance (data shows rectification. The rectification seen with these
ramps, however, must be treated cautiously, becausenot shown) in CA1 pyramidal cells in the mutant mice
instead of the outward current and decrease in input other K1 channels are activated at depolarized mem-
brane potentials, and this could shunt the baclofen-resistance (data not shown) observed in wild-type mice
(Figure 1B). In addition to 5-HT1A receptors, CA1 pyra- activated current. However, in acutely isolated cells
where recording conditions are better controlled, themidal cells possess 5-HT4 receptors, which close K1
channels (Andrade and Nicoll, 1987; Colino and Halliwell, baclofen-activated current has been shown to have all
the properties of inwardly rectifying channels (Sodick-1987; Andrade and Chaput, 1991). Given the increase
of the input resistance, it is presumably this latter current son and Bean, 1996).
that is unmasked in the mutant mice, strongly sug-
gesting that the channels closed by serotonin are dis- Absence of Monosynaptic Slow Inhibitory
tinct from those that are activated by serotonin. At high Postsynaptic Currents (IPSCs)
concentrations, the muscarinic agonist carbachol (.10 in GIRK22/2 CA1 Neurons
mM) closes two types of K1 channels, M channels and It is well established in the hippocampus that synapti-
cally released GABA generates a chloride-dependentleak channels (Madison et al., 1987; Benson et al., 1988;
Role of GIRKs in the Hippocampus
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Figure 2. Current±Voltage (I±V) Relationship
of a Residual Baclofen-Induced Current in the
GIRK22/2 Mouse
(A1) I±V curve recorded in a GIRK22/2 mouse
in the presence (dark trace) and absence
(light trace) of 40 mM baclofen at voltages
from 240 mV to 2140 mV, using a ramp of
250 ms duration (insets). Traces are averages
of five ramp protocols.
(A2) Identical experiment in GIRK21/1 mouse.
(B) Baclofen-inducedcurrent obtained by cal-
culating the difference between the I±V
curves before and after addition of baclofen
for mutant and wild-type mice (A1 and A2)
plotted on the same graph. Compared to con-
trol, the baclofen-induced current in the mu-
tant mouse is markedly reduced but not zero
(n 5 4 for each genotype). The residual cur-
rent is still inwardly rectifying and has a
slightly higher reversal potential. This current
could be mediated by remaining GIRK sub-
units, forming either heteromultimers or ho-
momultimers (see text for discussion).
fast inhibitory postsynaptic potential/current (IPSP/C) average resting membrane potential in the mutant mice
was z7.9 mV (unpaired t test, p , 0.0001) more depolar-mediated by GABAA receptors and a K1-dependent slow
IPSP/C mediated by GABAB receptors (Nicoll, 1988; Mis- ized than in the wild-type mice (Figure 4). One explana-
tion for this finding is that tonic activation of some Ggeld et al., 1995). We therefore tested for the presence of
this synaptic current in the mutant mice. Monosynaptic protein-coupled receptors leads to tonic activation of
GIRKs, which contributes to the membrane potential.slow IPSCs were isolated by blocking glutamate recep-
tors and GABAA receptors (see Experimental Proce- Although this scenario can not be completely ruled out,
two observations make it unlikely. First, blockade ofdures). While slow IPSCs were routinely recorded in the
wild-type mice, they were not seen in the mutant mice action potentials with tetrodotoxin had no effect on the
membrane potential in wild-type mice, indicating that(Figure 3A). To ensure that our stimulating electrode was
actually activating inhibitory interneurons, we monitored spontaneous action potential-dependent release of trans-
mitter does not tonically activate a K1 conductance (n 5the fast IPSC in the absence of GABAA receptor antago-
nists (Figure 3B). In this experiment, the membrane was 3; data not shown). Second, we applied high concentra-
tions of antagonists to block the receptors to the twoheld between ECl (247 mV, [Cl2]internal 5 20 mM for this
series of experiments) and EK (2103 mV), and thus the most likely candidates, GABAB receptors and adenosine
A1 receptors. Neither the GABAB receptor antagonistfast IPSC is inward and the slow IPSC is outward. De-
spite the large fast IPSC recorded in the mutant mouse, CGP 35348 (1 mM; n 5 3) nor the A1 antagonist
8-cyclopentyltheophylline (25 mM; n 5 3) had any effectno slow IPSC was recorded. We also varied the stimulus
strength and plotted the size of the fast IPSC (GABAA) on the resting membrane potential in wild-type mice
(data not shown). These observations raise the possibil-against the size of the slow IPSC (GABAB; Figure 3B3). In
the wild-type mouse, low stimulus strengths selectively ity that GIRKs, in the absence of receptor activation,
contribute to the resting membrane potential.activated the fast IPSC, but as the stimulus strength
was increased, a slow IPSC appeared, which quickly
reached a saturating level. On the other hand, in the Unimpaired Presynaptic Inhibition
in GIRK22/2 Hippocampusmutant mouse, even very high stimulus strengths only
activated the fast IPSC. Another major action of the G protein-coupled recep-
tors, particularly those which activate K1 currents post-
synaptically, is to presynaptically inhibit the release ofDepolarized Resting Membrane Potential
of GIRK22/2 Hippocampal Neurons neurotransmitter (Thompson et al., 1993; Wu and Sag-
gau, 1997). We therefore examined whether the presyn-If inwardly rectifying K1 channels contribute to the rest-
ing membrane potential (Vm), one would predict that Vm aptic actions of a variety of G protein receptor agonists
were normal in the mutant mouse. Typical experimentswould be depolarized in GIRK22/2. We therefore mea-
sured the Vm of a number of cells in current clamp. The for baclofen are shown in Figure 5A, both in wild-type
Neuron
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Figure 4. Depolarized Resting Membrane Potential in the GIRK22/2
Mouse
The resting membrane potential of CA1 principal cells measured in
current clamp (I 5 0) was depolarized by 7.9 mV in the GIRK22/2
mice compared to controls (unpaired t test, p , 0.0001; n 5 11,
2/2; n 5 12, 1/1). The absolute values (GIRK22/2 Vm 5 273.96 6
0.98 mV, GIRK21/1 Vm 5 81.85 6 1.28 mV; means 6 SEM) are cor-
rected for a junction potential of 15.6 mV. Boxplots show the median
(line at the center), the 25th percentile (top edge), and the 75th
percentile (bottom edge), as well as the 10th and 90th percentiles
(lines extending from the bottom and the top).
Figure 3. Synaptic Release of GABA Elicits IPSCs Mediated by
the CA1 region of the hippocampus. As was the caseGABAA but Not GABAB Receptors in GIRK22/2 Mice
for GABAB receptors, the presynaptic inhibition induced(A1) The slow, GABAB-mediated IPSC is absent in the GIRK22/2
mutant mouse. Currents were measured in whole-cell configuration by each one of these receptors, as well as the nonselec-
of a CA1 pyramidal cell, and excitatory and GABAA components of tive Ca21 channel blocker Cd21, was unaltered in the
the PSC were blocked by picrotoxin (100 mM), CNQX (20 mM), and mutant mice (Figure 5B). We also examined the presyn-
APV (50 mM). The small initial inward current is a residual GABAA aptic actions of baclofen, adenosine, and the mGluR
IPSC due to the strong stimulation intensity. Eachtrace is an average
agonist LCCG1 on mossy fiber synapses in the CA3of five sweeps.
region. Again, the presynaptic action of these agonists(A2) A control CA1 cell shows a typical slow IPSC.
(B1) Overlay of representative sweepsobtained by varying the stimu- was normal in the mutant mice (Figure 5B). It is possible
lus intensity and under conditions allowing a combined GABAA and that GIRK2 channels are present on the terminals but
GABAB IPSC. The membrane was held between ECl (247 mV, that their activation does not affect release. We therefore
[Cl2]internal 5 20 mM) and EK (2103 mV), and thus the fast IPSC is tested the effect of baclofen on the excitability of Schaf-
inward and the slow IPSC is outward. Notice the absence of a late
fer collateral fibers of CA3 pyramidal cells by monitoringoutward component of the current in the GIRK22/2 mouse.
the size of the antidromic volley generated in the CA3(B2) Control experiment in a wild-type CA1 cell showing a fast inward
current (GABAA) and a slow outward current (GABAB) which peaks pyramidal cell layer by Schaffer collateral fiber stimula-
at 250 ms. tion. Baclofen had no effect on fiber excitability (n 5 4),
(B3) Graph plotting the amplitude of the GABAB IPSC as a function suggesting that K1 channels were not activated on these
of the amplitude of the GABAA IPSC obtained from the experiments fibers.
in (B1) and (B2). At low stimulus intensities yielding small GABAA
The release of GABA from inhibitory interneurons isIPSCs, no GABAB IPSCs were measured in both groups, due to the
also controlled by presynaptic inhibitory receptors. Tohigher threshold of GABAB IPSCs. At higher stimulus intensities,
however, mutant mice still did not show any GABAB component, test the role of GIRK2 in mediating this action, mono-
whereas a slow IPSC was observed in controls. synaptic IPSCs were recorded in the presence of gluta-
mate receptor antagonists. Typical experiments of the
inhibitory action of baclofen on IPSCs are shown in
Figure 6A. In both the wild-type and the mutant mouse,and in mutant mice. Baclofen caused the same marked
depression in the field excitatory postsynaptic potential baclofen caused the same large depression of the IPSC
(Figure 6B). IPSCs are also inhibited presynaptically by(EPSP) inboth mouse strains.This depression was asso-
ciated with an increase in paired-pulse facilitation (PPF), opioid receptors (Cohen et al., 1992; Capogna et al.,
1993). The m opioid selective agonist DAMGO wasindicating a decrease in the probability of transmitter
release (Manabe et al., 1993). Presynaptic adenosine A1 equally effective in inhibiting IPSCs in the two groups
of animals (Figure 6B).receptors (Proctor and Dunwiddie, 1987; Thompson et
al., 1992), muscarinic receptors (Dutar and Nicoll, 1988a;
Pitler and Alger, 1992), metabotropic glutamate recep- Discussion
tors (mGluRs; Baskys and Malenka, 1991), and neuro-
peptide Y receptors (Colmers and Bleakman, 1994) also It is well established that there is a family of inhibitory
G protein-coupled receptors that can be expressed oninhibit transmitter release from excitatory synapses in
Role of GIRKs in the Hippocampus
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Figure 5. Agonist-Induced Presynaptic Inhibition in the CA1 and CA3 Region Is Unchanged in the GIRK22/2 Mouse
(A1) CA1 field EPSP in response to paired pulse stimulation (interpulse interval, 50 ms) in a GIRK22/2 mouse.
(Top) Representative traces showing the depression of the EPSP during the application of baclofen.
(Center) Normalized initial slope measurement of the first EPSP.
(Bottom) Paired pulse facilitation (PPF) increases during the application of baclofen, indicating the presynaptic nature of the inhibition.
(A2) Same experiment from a GIRK21/1 mouse.
(B) Summary graph of all agonists tested on CA1 and CA3 fields. None of the differences were significant (unpaired t test, p . 0.24; n 5 4±5
for each group and genotype). Fields in CA3 were obtained by mossy fiber stimulation. Concentrations applied were 40 mM baclofen (Baclo),
100 mM adenosine (Adeno), 1 mM carbachol (Carb), 10 mM trans-(1S,3R)-ACPD (tACPD), 100 nM neuropeptide Y (NPY), 10 mM LCCG1, and
100 mM cadmium (Cd).
the postsynaptic membrane as well as on the presynap- schin et al., 1996; but see Spauschus et al., 1996), as
well as the GIRK1 and 2 proteins (Liao et al., 1996; Draketic terminal. On the postsynaptic membrane, these re-
ceptors inhibit by activating a K1 conductance. The et al., 1997; Signorini et al., 1997) have been detected
at high levels in the hippocampus. Although GIRK2 hasmechanism for the presynaptic inhibitory action is not
entirely clear and could involve an increase in K1 con- been shown to form homomeric channels, GIRK1 does
not (Hedin et al., 1996). It is thought that coexpression ofductance and/or a more direct action on Ca21 channels
or the release process. The purpose of this study was GIRK1 and 2 results in the formation of both homomeric
GIRK2 channels and heteromeric GIRK 1/2 channelsto determine the type(s) of K1 channels involved in the
postsynaptic action and to elucidate the mechanism for (Kofuji et al., 1996; Slesinger et al., 1996). Interestingly,
in the GIRK22/2 mouse, GIRK1 expression is greatlythe presynaptic inhibition. We have used mice lacking
the GIRK2 channel (Signorini et al., 1997) to explore reduced (Signorini et al., 1997).
In these mutant mice, we have found that the postsyn-these issues.
aptic K1 conductance increase induced by a number of
G protein-coupled receptors, including GABAB, adeno-Lack of Postsynaptic K1 Conductances Activated
by GABAB, 5-HT1A, or Adenosine A1 Receptors sine A1, and serotonin 5-HT1A receptors, is markedly
reduced or absent. This indicates that all of these recep-Four types of mammalian GIRK channel subunits have
been cloned. mRNA for GIRK1±3, but not GIRK4 (Kar- tors couple to K1 channels that contain GIRK2 and/or
Neuron
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Figure 6. Presynaptic Inhibition of Monosyn-
aptic IPSCs in CA1 Pyramidal Cells Is Un-
changed in the GIRK22/2 Mouse
(A1) Monosynaptic IPSCs were recorded in the
presence of CNQX (20 mM) and APV (50 mM).
(Top) Representative traces (average of 20
sweeps) show the baclofen-induced depres-
sion in a GIRK22/2 mutant mouse.
(Bottom) Normalized IPSC amplitude as a
function of time; stimulation frequency, 0.1 Hz.
(A2) Same experiment from a GIRK21/1 cell.
(B) Summary graph comparing the residual
IPSC amplitude in both groups during the ap-
plication of baclofen (40 nM) or the m opioid
agonist DAMGO (100 nM). No significant dif-
ference was observed (p . 0.2) between ge-
notypes.
GIRK1 and is consistent with previous results sug- synaptic activation in the mutant mice. However, its
presence was variable and, when present, accountedgesting that these receptorsshare the same K1 channels
(Andrade et al., 1986). These findings, however, are diffi- for a very small part of the total current. This residual
current might be due to a GIRK3 channel subunit eithercult to reconcile with previous results claiming that the
single K1 channel conductance evokedby serotonin and alone or together with the GIRK1, which, although it is
down-regulated in the mutant mice, is still present inbaclofen differ (Premkumar and Gage, 1994). Moreover,
the single channel conductances for GIRK homomeric small amounts (Signorini et al., 1997).
The resting membrane potential of CA1 pyramidalor heteromeric channels (Kubo et al., 1993; Duprat et
al., 1995) are similar to the single channel conductance cells in the mutant mice was z7.9 mV depolarized com-
pared to wild-type mice. The GIRK contribution to thereported by Premkumar and Gage for channels acti-
vated by serotonin but not baclofen. For all of these resting membrane potential in wild-type mice was not
due to the tonic activation of either GABAB or adenosineresults to be consistent with our observations, one
would have to postulate that while the same channels receptors. While it is still possible that the tonic activa-
tion of some unidentified receptor accounts for the GIRKare activated by both agonists, the single channel prop-
erties depend on the receptor type that activates the contribution, the results suggest that there is a basal
GIRK activity that occurs in the absence of receptorchannels, or that different agonists couple to GIRK2-
containing channels of different subunit stoichiometry. stimulation. This is consistent with the observation that
GIRK channel activity can occur in a G protein-indepen-While it was originally proposed that baclofen and
GABA, either endogenously released or exogenously dent manner (Sui et al., 1996).
applied, activate the same conductance mechanism (Ni-
coll, 1988; Dutar and Nicoll, 1988b), other studies have GIRK22/2 Mice Show Normal Inhibition of Leak
K1 Conductance by Muscarinic Receptorsargued that different conductances are involved (Ogata
et al., 1987; MuÈ ller and Misgeld, 1989; Jarolimek et al., and Normal Presynaptic Inhibition
of EPSCs As Well As IPSCs1994). For instance, it has been reported that intracellu-
lar Cs1 blocks outward baclofen-induced currents but Muscarinic receptor activation is known to block a leak
K1 conductance as well as the muscarine current (Madi-has no effect on the slow GABAB-mediated IPSC (Jaroli-
mek et al., 1994), and thus the authors proposed that son et al., 1987; Benson et al., 1988). Given that GIRKs
contribute to the resting membrane potential, we con-different K1 channels were activated. However, the
present findings would appear to favor the conclusion sidered the possibility that muscarinic receptor activa-
tion might inhibit this tonic GIRK activity. However, thethat baclofen activates the same type of K1 channels
as activated by endogenously released GABA. There finding that concentrations of carbachol, which selec-
tively reduce the leak K1 conductance, had the samewas a residual current activated by baclofen but not by
Role of GIRKs in the Hippocampus
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Figure 7. G Protein-Coupled Receptors, in
Response to the Same Agonist, Exert Their
Effects through Different Mechanisms Ac-
cording to Their Location in the Neuron
Agonists bind to G protein-coupled receptors
at two locations on a pyramidal neuron (PN).
Theiractivation leads, in the presence of GTP,
to the cleavage of the a subunit of the hetero-
trimeric G protein complex. At the somato-
dendritic membrane, the bg subunit can then
activate inwardly rectifying K1 channels,
yielding an outward current and a hyperpo-
larization of the neuron. At the presynaptic
terminal, the same agonist also activates G
protein-coupled receptors, which leads to
presynaptic depression by a GIRK-indepen-
dent signaling mechanism, such as the inhibi-
tion of Ca21 channels or an interaction with
the release machinery.
action in the wild-type and mutant mice indicates that In summary, all of the receptors that are known to
increase postsynaptic K1 conductance in the hippo-the channels closed by muscarinic receptors are distinct
from those opened by G protein-coupled receptors. This campus require the presence of GIRK2 subunits. On the
other hand, the presynaptic inhibition mediated by theseis also the case for the inhibition of K1 channels by
5-HT4 receptors (Andrade and Nicoll, 1987; Andrade same receptors is unaltered by GIRK2 deletion. Thus,
the same receptor can couple to distinct effector sys-and Chaput, 1991), since this action remained intact in
GIRK22/2 mice. tems in the same neuron, depending upon the subcellu-
lar location of the receptor.The finding that virtually all G protein-coupled recep-
tors that activate K1 channels postsynaptically can also
Experimental Proceduresinhibit transmitter release presynaptically raises the
possibility that GIRKs might play a role in this presynap-
The GIRK22/2 mice were obtained from GIRK22/1 matings (derivedtic inhibition. For instance, it has been reported that the
from 129/sv±C57BL/6 hybrid crosses). Control animals were
K1 channel blocker Ba21 can block the GABAB-mediated GIRK21/1 littermates and C57BL/6 mice. The genotype was deter-
presynaptic inhibition (Misgeld et al., 1989; Thompson mined by PCR amplification of genomic DNA isolated from mouse
tails. Standard hippocampal slices were prepared from 2- to 8-week-and GaÈ hwiler, 1992; but see Lambert et al., 1991). We
old mice. The recording chamber was superfused (1±2 ml/min) withtherefore compared the presynaptic inhibitory action of
an external solution containing (inmM) 119 NaCl, 2.5 KCl, 1.3 MgSO4,a number of G protein-coupled receptors in the two
2.5 CaCl2, 1.0 NaH2PO4, 26.2 NaHCO3, and 11 glucose. All experi-groups of mice. These included GABAB, adenosine A1, ments were carried out at room temperature. Either extracellular
NPY, and mGluRs on excitatory synapses and GABAB field potential recording or whole-cell voltage-clamp recording was
and m opioid receptors on inhibitory synapses. The ab- used. Field potentials were made with a glass pipette filled with 2
M NaCl. To evoke synaptic potentials, stimuli (0.1 ms duration) weresence of GIRK2 had no effect on the inhibitory action
delivered at 0.1 Hz through bipolar stainless steel electrodes. Whole-of any of these receptors. In particular, while the GABAB-
cell recordings were madefrom principal cells using a ªblindº whole-mediated postsynaptic K1 conductance increase in CA3
cell recording technique with patch pipettes (3±5 MV) filled withpyramidal cells was abolished in the mutant mouse, the
either of two internal solutions. For recording K1 currents or GABAB-GABAB-mediated presynaptic inhibition of transmitter mediated IPSCs, a solution containing (in mM) 140 K-Gluconate, 5
release from the synapses made by these CA3 cells on HEPES, 2 MgCl2, 1.1 EGTA, 2 MgATP, and 3 Na3GTP was used. For
recording monosynaptic IPSCs (Figure 6), a solution containing (inCA1 cells was entirely normal. This indicates that GABAB
mM) 117 CsOH, 117 gluconic acid, 2.5 CsCl, 8 NaCl, 10 HEPES, 10receptors on the same neuron exert mechanistically dis-
BAPTA, 2 MgATP, and 3 Na3GTP was used. Voltage measurementstinct forms of inhibition depending on the location of
were corrected for the liquid junction potential (15.6 mV) of thethese receptors (Figure 7). The lack of GIRK involvement
standard internal solution (PPT Software by F. Mendez, MPI, GoÈ tti-
in presynaptic inhibition could be due to the lack of gen, Federal Republic of Germany).
GIRKs at the synapse or to the failure of GIRK activation Recordings were amplified with an Axopatch 1D or Axoclamp 2B,
filtered at 2 kHz, digitized at 5±10 kHz (National Instruments Boardat the synapse to alter transmitter release. The absence
MIO-16, NI-DAQ Igor 3.01 Software, Wave Metrics), and stored onof any effect of baclofen on fiber excitability favors the
a hard disk. In CA1 field recordings, initial slopes were measured,former hypothesis, at least for the excitatory synapses
and for mossy fiber fields the amplitude of the second response ofin the CA1 region, and consistent with this conclusion
a double stimulus (20 ms interpulse interval) was calculated. Data
is the finding that immunoreactivity for GIRK1 is re- are expressed as means 6 SEM. Drugs used were CNQX (Tocris),
stricted to the soma and dendrites of hippocampal neu- APV (Sigma), picrotoxin, 6baclofen (RBI), adenosine (Sigma), 5-HT
(Sigma), trans-(1S,3R)-ACPD (RBI), carbachol (Sigma),neuropeptiderons (Drake et al., 1997). In either case, the results of
Y (RBI), DAMGO (RBI), and LCCG1 (Tocris).this study suggest that the presynaptic inhibitory action
of G protein-coupled receptors in the hippocampus is
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